W. Smalley, D. Shatin, D. Wysowski, J. Gurwitz, S. Andrade et al., Contraindicated Use of Cisapride, JAMA, vol.284, issue.23, pp.3036-3045, 2000.
DOI : 10.1001/jama.284.23.3036

G. Lande, Le syndrome du QT long acquis. Thèse d'exercice : Médecine : Université de Nantes, 2007.

S. Al-khatib, N. Lapointe, J. Kramer, and R. Califf, What Clinicians Should Know About the QT Interval, JAMA, vol.289, issue.16, pp.2120-2127, 2003.
DOI : 10.1001/jama.289.16.2120

M. Ponte, G. Keller, D. Girolamo, and G. , Mechanisms of Drug Induced QT Interval Prolongation, Current Drug Safety, vol.5, issue.1, pp.44-53, 2010.
DOI : 10.2174/157488610789869247

Y. Yap and A. Camm, Drug induced QT prolongation and torsades de pointes, Heart, vol.89, issue.11, pp.1363-72, 2003.
DOI : 10.1136/heart.89.11.1363

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1767957

D. Roden, Drug-Induced Prolongation of the QT Interval, N Engl J Med, vol.350, issue.10, pp.1013-1035, 2004.

J. Tisdale and . Chapter, Ventricular arrythmias. Drug-induced diseases: prevention, detection, and management, pp.491-515, 2010.

P. Kannankeril and D. Roden, Drug-induced long QT and torsade de pointes: recent advances, Current Opinion in Cardiology, vol.22, issue.1, pp.39-43, 2007.
DOI : 10.1097/HCO.0b013e32801129eb

P. Taboulet, Terminologie -Torsades de pointes

. Medscape, Torsade de Pointes, p.6, 2015.

. Service-de-cardiologie-de-besançon, Exemple de torsade de pointe chez un patient avec prolongation congénitale de l'intervalle QT, 2015.

S. Poelzing and D. Rosenbaum, Cellular Mechanisms of Torsade de Pointes, Novartis Found Symp, vol.266, pp.204-228, 2005.
DOI : 10.1002/047002142X.ch16

D. Zipes, A. Camm, M. Borggrefe, and A. Buxton, ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death, European Heart Rhythm Association, pp.247-346, 2006.
DOI : 10.1016/j.jacc.2006.07.010

M. Molokhia, A. Pathak, M. Lapeyre-mestre, L. Caturla, J. Montastruc et al., Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France, British Journal of Clinical Pharmacology, vol.105, issue.K, pp.386-95, 2008.
DOI : 10.1111/j.1365-2125.2008.03229.x

URL : https://hal.archives-ouvertes.fr/inserm-00409223

. Crediblemeds, QTDrugs list. https://www.crediblemeds.org/index, p.32806, 2015.

J. Tisdale and . Chapter, Ventricular arrythmias. Drug-induced diseases: prevention, detection, and management, pp.491-515, 2010.

C. Van-noord, M. Eijgelsheim, and B. Stricker, Drug- and non-drug-associated QT interval prolongation, British Journal of Clinical Pharmacology, vol.115, issue.1, pp.16-23, 2010.
DOI : 10.1111/j.1365-2125.2010.03660.x

M. Dumoulin and K. , Cardiotoxicit?? des??antihistaminiques de??deuxi??me g??n??ration, Revue Fran??aise d'Allergologie et d'Immunologie Clinique, vol.46, issue.4, pp.392-401, 2006.
DOI : 10.1016/j.allerg.2006.05.001

D. Zeltser, D. Justo, A. Halkin, V. Prokhorov, K. Heller et al., Torsade de Pointes Due to Noncardiac Drugs, Medicine, vol.82, issue.4, pp.282-90, 2003.
DOI : 10.1097/01.md.0000085057.63483.9b

L. Hondeghem, TRIad: Foundation for Proarrhythmia (Triangulation, Reverse Use Dependence and Instability), Novartis Found Symp, vol.266, pp.235-50, 2005.
DOI : 10.1002/047002142X.ch18

T. Yang and D. Roden, Extracellular Potassium Modulation of Drug Block of IKr : Implications for Torsade de Pointes and Reverse Use-Dependence, Circulation, vol.93, issue.3, pp.407-418, 1996.
DOI : 10.1161/01.CIR.93.3.407

A. Grant and J. Tranquillo, Action Potential and QT Prolongation Not Sufficient to Cause Torsade de Pointes: Role of Action Potential Triangulation, Journal of Cardiovascular Electrophysiology, vol.18, issue.2, pp.204-209, 2007.
DOI : 10.1016/S0008-6363(99)00035-8

J. Van-opstal, M. Schoenmakers, S. Verduyn, S. De-groot, J. Leunissen et al., Chronic Amiodarone Evokes No Torsade de Pointes Arrhythmias Despite QT Lengthening in an Animal Model of Acquired Long-QT Syndrome, Circulation, vol.104, issue.22, pp.2722-2729, 2001.
DOI : 10.1161/hc4701.099579

S. Hohnloser, T. Klingenheben, and B. Singh, Amiodarone-associated Proarrhythmic Effects: A Review with Special Reference to Torsade de Pointes Tachycardia, Annals of Internal Medicine, vol.121, issue.7, pp.529-564, 1994.
DOI : 10.7326/0003-4819-121-7-199410010-00009

S. Canada and . Ligne-directrice, Allongement de l'intervalle QT/QTc : Contenu des monographies de produit, p.6, 2015.

R. Makkar, B. Fromm, R. Steinman, M. Meissner, and M. Lehmann, Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs, JAMA: The Journal of the American Medical Association, vol.270, issue.21, pp.2590-2597, 1993.
DOI : 10.1001/jama.1993.03510210076031

A. Varró and I. Baczkó, Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk, British Journal of Pharmacology, vol.111, issue.1, pp.14-36, 2011.
DOI : 10.1111/j.1476-5381.2011.01367.x

A. James, S. Choisy, and J. Hancox, Recent advances in understanding sex differences in cardiac repolarization, Progress in Biophysics and Molecular Biology, vol.94, issue.3, pp.265-319, 2007.
DOI : 10.1016/j.pbiomolbio.2005.05.010

R. Hreiche and J. Turgeon, Interactions médicamenteuse et risque de torsades de pointes, Pharmactuel, vol.38, issue.3, pp.134-143, 2005.

S. Al-khatib, N. Lapointe, J. Kramer, and R. Califf, What Clinicians Should Know About the QT Interval, JAMA, vol.289, issue.16, pp.2120-2127, 2003.
DOI : 10.1001/jama.289.16.2120

. Orphanet and . Syndrome, php?lng=FR&data_id=658&Disease_Disease_Search_diseaseGroup=syn drome-du-qtlong&Disease_Disease_Search_diseaseType=Pat&Maladie(s )/groupes%20de%20maladies= Syndrome-du-QT-long-familial--Syndrome-du-QT-long-congenital-&title=Syndrome-du- QT-long-familial--Syndrome-du-QT-long-congenital-&search=Disease_Search_Simple

A. Varró and I. Baczkó, Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk, British Journal of Pharmacology, vol.111, issue.1, pp.14-36, 2011.
DOI : 10.1111/j.1476-5381.2011.01367.x

A. Blogue and . L-'opinion-pharmaceutique, Ordre national des pharmaciens. Dispensation des produits de santé. www.ordre.pharmacien.fr, 2015.

L. Beaume, De la prescription à la dispensation : état des connaissances des prescripteurs, intérêt de la relation médecin-pharmacien, impact pour le patient et méthodes d'amélioration. Thèse d'exercice : Pharmacie : Université Grenoble 1, 2014.